Progressive systemic sclerosis in Egyptian patients: Clinical characteristics and nail fold capillaroscopy

Smith, 2012, Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study, Ann Rheum Dis, 71, 1636, 10.1136/annrheumdis-2011-200780 Assassi, 2010, Systemic sclerosis and lupus: points in an interferon-mediated continuum, Arthritis Rheum, 62, 589, 10.1002/art.27224 Hummers, 2013, Scleroderma, 1738 Gelber, 2013, Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature, Medicine, 92, 191, 10.1097/MD.0b013e31829be125 Furst D, Mayes M, McSweeney P, Nash R, Sullivan K and Wallace D. Scleroderma and the SCOT STUDY www.sclerodermatrial.org/physicians/downloads/mono; 2005. Allanore, 2015, Sysemic sclerosis, Nat Rev Dis Primers, 1, 15002, 10.1038/nrdp.2015.2 Bassyouni, 2011, Clinical significance of serum levels of sCD36 in patients with systemic sclerosis: preliminary data, Rheumatology (Oxford), 50, 2108, 10.1093/rheumatology/ker297 Alzawawy, 2011, Serum soluble vascular cell adhesion molecule-1 (sVCAM-1) in scleroderma patients and its relation to pulmonary involvement and disease activity, Egypt Rheumatol, 33, 21, 10.1016/j.ejr.2010.06.001 Gheita, 2017, Toll-like receptor 9 in systemic sclerosis patients: relation to modified Rodnan skin score, disease severity, and functional status, Clin Rheumatol Gheita, 2012, Cartilage Oligomeric Matrix Protein (COMP) in systemic sclerosis (SSc): role in disease severity and subclinical rheumatoid arthritis overlap, Joint Bone Spine, 79, 51, 10.1016/j.jbspin.2011.02.022 Hafez, 2018, Pulmonary manifestations in Egyptian patients with systemic sclerosis, Egypt Rheumatol, 40, 39, 10.1016/j.ejr.2017.06.004 Gheita, 2014, Potential effect of Sildenafil beyond pulmonary hypertension in a patient with diffuse systemic sclerosis and cryoglobulinemic vasculitis, Springerplus, 3, 559, 10.1186/2193-1801-3-559 Tarek, 2006, Coronary angiographic findings in asymptomatic systemic sclerosis, Clin Rheumatol, 25, 487, 10.1007/s10067-005-0073-5 Bader El-Din, 2016, Determinants of atherosclerosis in an Egyptian cohort of systemic sclerosis: Relation to disease activity and severity, Egypt Rheumatol, 38, 195, 10.1016/j.ejr.2015.11.003 Van den Hoogen, 2013, 2013 classification criteria for systemic sclerosis: an american college of rheumatology/european league against rheumatism collaborative initiative, Arthritis Rheum, 65, 2737, 10.1002/art.38098 Clements, 1995, Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis, J Rheumatol, 22, 1281 Cockcroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580 Cutolo, 2016, Systemic sclerosis: markers and targeted treatments, Acta Reumatol Port, 41, 18 Simeón-Aznar, 2012, Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status, Semin Arthritis Rheum, 41, 789, 10.1016/j.semarthrit.2011.10.004 Ghosh, 2012, Mucocutaneous and demographic features of systemic sclerosis: a profile of 46 patients from Eastern India, Indian J Dermatol, 57, 201, 10.4103/0019-5154.96193 Mayes, 2003, Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population, Arthritis Rheum, 48, 2246, 10.1002/art.11073 Tolosa-Vilella, 2016, Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry, Semin Arthritis Rheum, 46, 200, 10.1016/j.semarthrit.2016.04.007 Chaudhary, 2011, Cigarette smoking is not a risk factor for systemic sclerosis, Arthritis Rheum, 63, 3098, 10.1002/art.30492 Hudson, 2011, Cigarette smoking in patients with systemic sclerosis, Arthritis Rheum, 63, 230, 10.1002/art.30071 Guidolin, 2005, Prevalence of cutaneous findings in systemic sclerosis patients: experience of a teaching hospital, An Bras Dermatol, 80, 481, 10.1590/S0365-05962005000600005 Ooi, 2003, Interstitial lung disease in systemic sclerosis, Acta Radiol, 44, 258 Bhakuni, 2012, Nailfold capillaroscopy by digital microscope in an Indian population with systemic sclerosis, Int J Rheum Dis, 15, 95, 10.1111/j.1756-185X.2011.01699.x McNearney, 2007, Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors, Arthritis Rheum, 57, 318, 10.1002/art.22532 Jehangir, 2015, Nail fold capillaroscopy in patients of systemic sclerosis and its association with disease severity as evidenced by high resolution computed tomography lung: a hospital based cross sectional study, Int J Res Med Sci, 3, 3485, 10.18203/2320-6012.ijrms20151223 Sumphao-Ngern, 2015, Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis, Arch Med Sci, 11, 1255, 10.5114/aoms.2015.56352 Solomon, 2013, Scleroderma lung disease, Eur Respir Rev, 22, 6, 10.1183/09059180.00005512 Steen, 2000, Severe organ involvement in systemic sclerosis with diffuse scleroderma, Arthritis Rheum, 43, 2437, 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U Pagalavan, 2007, Demography, clinical and laboratory features of systemic sclerosis in a Malaysian rheumatology centre, Med J Malaysia, 62, 117 Ilovi, 2013, Characteristics of systemic sclerosis patients in Nairobi, Kenya: a retrospective study, Afr J Rheumatol, 1, 8 Chang, 2003, Scleroderma patients with combined pulmonary hypertension and interstitial lung disease, J Rheumatol, 30, 2398